Carnitine transporter OCTN2 mutations in systemic primary carnitine deficiency: A novel Arg169Gln mutation and a recurrent Arg282ter mutation associated with an unconventional splicing abnormality
B. Burwinkel et al., Carnitine transporter OCTN2 mutations in systemic primary carnitine deficiency: A novel Arg169Gln mutation and a recurrent Arg282ter mutation associated with an unconventional splicing abnormality, BIOC BIOP R, 261(2), 1999, pp. 484-487
Citations number
19
Language
INGLESE
art.tipo
Article
Categorie Soggetti
Biochemistry & Biophysics
Journal title
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
Systemic primary carnitine deficiency (CDSP, MIM 212140) is a disorder of f
atty acid oxidation manifesting in acute metabolic decompensation or in pro
gressive cardiomyopathy and muscle weakness. Mutations in the plasmalemmal
organic cation/carnitine transporter OCTN2 were recently identified in CDSP
patients of diverse ethnic backgrounds. We have performed OCTN2 mutation a
nalysis in two unrelated German patients with primary carnitine deficiency
and identified three molecular abnormalities. On one of the four chromosome
s analyzed, we detected an Arg169Gln missense mutation that affects an argi
nine residue absolutely conserved in the entire transporter superfamily to
which OCTN2 belongs. On the three other chromosomes, we found an Arg282ter
nonsense mutation in exon 5. This mutation is embedded into different haplo
types of closely spaced intragenic dimorphisms in our two patients and was
recently described in a patient of Asiatic Indian background, so it appears
to be a recurrent or ancient founder mutation that may account for more CD
SP cases. Finally, we found that the Arg282ter nonsense mutation is associa
ted with a splicing abnormality at the intron 6/exon 7 junction. However, n
o mutations are present in exon 6, intron 6, or exon 7, suggesting that def
ective splicing of exon 7 on the Arg282ter allele is due to an unconvention
al, long-distance mechanism. (C) 1999 Academic Press.